Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience.

Stefanini GF, Amorati P, Biselli M, Mucci F, Celi A, Arienti V, Roversi R, Rossi C, Re G, Gasbarrini G.

Cancer. 1995 May 15;75(10):2427-34.

2.

Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor.

Biselli M, Forti P, Mucci F, Foschi FG, Marsigli L, Caputo F, Ravaglia G, Bernardi M, Stefanini GF.

J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):M305-9.

PMID:
9310085
3.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y; Liver Cancer Study Group of Japan.

Gastroenterology. 2006 Aug;131(2):461-9.

PMID:
16890600
4.

Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.

Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.

Am J Gastroenterol. 2003 May;98(5):1181-5.

PMID:
12809846
5.

Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.

Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.

J Nucl Med. 2009 Jun;50(6):871-7. doi: 10.2967/jnumed.108.060558. Epub 2009 May 14.

7.

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.

Molinari M, Kachura JR, Dixon E, Rajan DK, Hayeems EB, Asch MR, Benjamin MS, Sherman M, Gallinger S, Burnett B, Feld R, Chen E, Greig PD, Grant DR, Knox JJ.

Clin Oncol (R Coll Radiol). 2006 Nov;18(9):684-92.

PMID:
17100154
8.

Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.

Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R.

Dig Dis Sci. 1996 Dec;41(12):2332-9.

PMID:
9011438
9.

[High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].

Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H.

Zhonghua Zhong Liu Za Zhi. 2003 Jul;25(4):401-3. Chinese.

PMID:
12921577
10.

Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).

Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G.

Eur Radiol. 2006 Mar;16(3):661-9. Epub 2005 Oct 14.

PMID:
16228211
11.

Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma.

Kamada K, Kitamoto M, Aikata H, Kawakami Y, Kono H, Imamura M, Nakanishi T, Chayama K.

Am J Surg. 2002 Sep;184(3):284-90.

PMID:
12354601
12.

[Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].

Chen M, Li J, Zhang Y.

Zhonghua Zhong Liu Za Zhi. 2001 Mar;23(2):165-7. Chinese.

PMID:
11783027
13.

Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, Rossi C, Ricca Rosellini S, Cammà C, Lorenzini S, Stefanini GF, Gasbarrini G, Bernardi M.

Clin Gastroenterol Hepatol. 2005 Sep;3(9):918-25.

PMID:
16234031
14.

Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.

Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.

J Gastroenterol Hepatol. 2009 Aug;24(8):1437-44. doi: 10.1111/j.1440-1746.2009.05863.x. Epub 2009 May 28.

PMID:
19486255
15.

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.

Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J.

Hepatology. 2002 May;35(5):1164-71.

PMID:
11981766
17.

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.

Mabed M, Esmaeel M, El-Khodary T, Awad M, Amer T.

Eur J Cancer Care (Engl). 2009 Sep;18(5):492-9. doi: 10.1111/j.1365-2354.2008.00984.x.

PMID:
19453695
18.
19.

Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.

Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Mori T, Oda T.

Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-38-S6-45.

PMID:
9151915
20.

Supplemental Content

Support Center